Merck Tbk. vs Super Bank Indonesia Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Super Bank Indonesia Tbk. trades at Rp590 (market cap 19.63T, 9.84M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 11.5× Merck Tbk.'s market cap, and Super Bank Indonesia Tbk. is more actively traded (9.84M versus 37.6K). Which is the better fit depends on your goals.
| MERK | SUPA | |
|---|---|---|
Market Cap | 1.7T | 19.63T |
Volume | 37.6K | 9.84M |
Lot | 376 | 98.38K |
Turnover | 144.47M | 5.78B |
Average Price | 3,842.23 | 587.51 |
Value | 144.47M | 5.78B |
Indicative Equilibrium Price | 3,840 | 590 |
Indicative Equilibrium Volume | 7 | 803 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →